MUFG Securities EMEA’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,745,600
Closed -$148M 489
2020
Q3
$148M Buy
1,745,600
+1,712,000
+5,095% +$86.6M 1.41% 9
2020
Q2
$1.19M Buy
+33,600
New +$982K 0.01% 332

MUFG Securities EMEA's IMMU Position: Q4 2020 in Review

MUFG Securities EMEA sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 1,745,600 shares — an estimated $148M sold.

MUFG Securities EMEA first reported a position in IMMU in Q2 2020 and held it in 2 quarters. The position peaked at $148M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • MUFG Securities EMEA reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • MUFG Securities EMEA sold 1,745,600 Immunomedics Inc shares in Q4 2020, an estimated $148M.
  • MUFG Securities EMEA first reported a position in Immunomedics Inc in Q2 2020 and held it in 2 quarters.
  • MUFG Securities EMEA's Immunomedics Inc position peaked at $148M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on MUFG Securities EMEA's 13F filing for Q4 2020, filed 11 Feb 2021.